MDSCs in liver cancer: A critical tumor-promoting player and a potential therapeutic target
- 1 March 2021
- journal article
- research article
- Published by Elsevier BV in Cellular Immunology
- Vol. 361, 104295
- https://doi.org/10.1016/j.cellimm.2021.104295
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 99 references indexed in Scilit:
- Gr-1+ CD11b+ Myeloid-derived Suppressor Cells Suppress Inflammation and Promote Insulin Sensitivity in ObesityOnline Journal of Public Health Informatics, 2011
- Risk factors for cholangiocarcinomaHepatology, 2011
- The seed and soil hypothesis revisited—The role of tumor‐stroma interactions in metastasis to different organsInternational Journal of Cancer, 2011
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF ExpressionCell, 2010
- The Liver Is a Site for Tumor-Induced Myeloid-Derived Suppressor Cell Accumulation and ImmunosuppressionCancer Research, 2009
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis: Integrative Cancer Research, 2009
- Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma PatientsClinical Cancer Research, 2009
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T CellsGastroenterology, 2008
- Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma in the United States: A Population-Based Case-Control StudyClinical Gastroenterology and Hepatology, 2007